Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

AMPLATZER Duct Occluder II Clinical Study

Study:

Closure of Patent Ductus Arteriosus With the AMPLATZER DUCT Occluder II

Rationale:

n/a

Purpose:

The objective of this study is to investigate the safety and effectiveness of the ADO II in patients with a PDA.

Study Status: Active, not recruiting

Recruiting:
n/a

Condition Intervention Phase
Patent Ductus Arteriosus Device: AMPLATZER Duct Occluder II N/A

Verified by AGA Medical Corporation June, 2012

Sponsored by: AGA Medical Corporation
Information provided by: AGA Medical Corporation
ClinicalTrials.gov identifier: NCT00713700

Study Type: Interventional

Study Design: Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

The Children`s Hospital at Cleveland Clinic
Cleveland, Ohio 44195
United States

n/a

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.